FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313204511> ?p ?o ?g. }

• W4313204511 endingPage "270" @default.
• W4313204511 startingPage "260" @default.
• W4313204511 abstract "Hypertrophic scars are fibroproliferative illnesses caused by improper wound healing, during that, excessive inflammation, angiogenesis, and differentiated human dermal fibroblast (HDF ) function contribute to scarring, whereas hyperpigmentation negatively affects scar quality. Over 100 million patients heal with a scar every year. To investigate the role of the beta 2 adrenergic receptor (β2AR); Ritodrine, in wound scarring, the ability of beta 2 adrenergic receptor agonist (β2ARag) to alter HDF differentiation and function, wound inflammation, angiogenesis, and wound scarring was explored in HDFs, zebrafish, chick chorioallantoic membrane assay (CAM), and a porcine skin wound model, respectively. A study identify a β2AR-mediated mechanism for scar reduction. β2ARag significantly reduced HDF differentiation, via multiple cAMP and/or fibroblast growth factor 2 or basic FGF (FGF2)-dependent mechanisms, in the presence of transforming growth factor betaβ1, reduced contractile function, and inhibited mRNA expression of a number of profibrotic markers. β2ARag also reduced inflammation and angiogenesis in zebrafish and CAMs in vivo, respectively. In Red Duroc pig full-thickness wounds, β2ARag reduced both scar area and hyperpigmentation by almost 50% and significantly improved scar quality. Indeed, mechanisms delineated in vitro and in other in vivo models were evident in the β2ARag-treated porcine scars in vivo. Both macrophage infiltration and angiogenesis were initially decreased, whereas DF function was impaired in the β2ARag-treated porcine wound bed. This data reveal the potential of β2ARag to improve skin scarring. The purpose of this study was to assess the therapeutic effect of topical Ritodrine hydrochloride on hypertrophic scars in rabbits. Thirty-two healthy male albino rabbits that divided in to 4 groups were included in the study (healthy; induced untreated hypertrophic scars; induced hypertrophic scars treated with 0.1% Triamcinolone acetonide (TAC) as a standard drug; and induced hypertrophic scars treated with 0.5% Ritodrine HCL gel twice daily for 21 days. Histopathology of skin sections, transforming growth factor beta1 TGFβ-1 level, and collagen III alpha1 in skin tissue were all used as outcome measures. Compared to the induced hypertrophic scar group; treatment with Ritodrine significantly reduced means of TGF β1 and collagen III (p ≤0.01); significantly reduce mean score of inflammation (p ≤0.001), significantly lowered scar size (P ≤ 0.001), and significantly lower mean scar height (P≤0.001), but no significant decrease in SEI (P>0.05). Therapy of induced hypertrophic scar with topical Ritodrine was successfully effective in rabbits. It reduced the immunological score (TGF-β1, collagen III), inflammation, and scar size in a substantial way. This effect was comparable (except in terms of SEI) to topical Triamcinolone acetonide efficacy" @default.
• W4313204511 created "2023-01-06" @default.
• W4313204511 creator A5015570001 @default.
• W4313204511 creator A5023013615 @default.
• W4313204511 creator A5049081035 @default.
• W4313204511 creator A5051868522 @default.
• W4313204511 date "2022-12-25" @default.
• W4313204511 modified "2023-10-14" @default.
• W4313204511 title "Role of Topical Ritodrine Hydrochloride in Experimentally Induced Hypertrophic Scar in Rabbits" @default.
• W4313204511 doi "https://doi.org/10.31351/vol31iss2pp260-270" @default.
• W4313204511 hasPublicationYear "2022" @default.
• W4313204511 type Work @default.
• W4313204511 citedByCount "0" @default.
• W4313204511 crossrefType "journal-article" @default.
• W4313204511 hasAuthorship W4313204511A5015570001 @default.
• W4313204511 hasAuthorship W4313204511A5023013615 @default.
• W4313204511 hasAuthorship W4313204511A5049081035 @default.
• W4313204511 hasAuthorship W4313204511A5051868522 @default.
• W4313204511 hasBestOaLocation W43132045111 @default.
• W4313204511 hasConcept C126322002 @default.
• W4313204511 hasConcept C141071460 @default.
• W4313204511 hasConcept C142724271 @default.
• W4313204511 hasConcept C150903083 @default.
• W4313204511 hasConcept C170493617 @default.
• W4313204511 hasConcept C185592680 @default.
• W4313204511 hasConcept C202751555 @default.
• W4313204511 hasConcept C207001950 @default.
• W4313204511 hasConcept C2775960820 @default.
• W4313204511 hasConcept C2776561140 @default.
• W4313204511 hasConcept C2776914184 @default.
• W4313204511 hasConcept C2777587049 @default.
• W4313204511 hasConcept C2777642821 @default.
• W4313204511 hasConcept C2778698245 @default.
• W4313204511 hasConcept C2779234561 @default.
• W4313204511 hasConcept C2780269544 @default.
• W4313204511 hasConcept C2780381497 @default.
• W4313204511 hasConcept C2780394083 @default.
• W4313204511 hasConcept C2780559512 @default.
• W4313204511 hasConcept C46973012 @default.
• W4313204511 hasConcept C54355233 @default.
• W4313204511 hasConcept C55493867 @default.
• W4313204511 hasConcept C71924100 @default.
• W4313204511 hasConcept C74373430 @default.
• W4313204511 hasConcept C86803240 @default.
• W4313204511 hasConcept C98274493 @default.
• W4313204511 hasConceptScore W4313204511C126322002 @default.
• W4313204511 hasConceptScore W4313204511C141071460 @default.
• W4313204511 hasConceptScore W4313204511C142724271 @default.
• W4313204511 hasConceptScore W4313204511C150903083 @default.
• W4313204511 hasConceptScore W4313204511C170493617 @default.
• W4313204511 hasConceptScore W4313204511C185592680 @default.
• W4313204511 hasConceptScore W4313204511C202751555 @default.
• W4313204511 hasConceptScore W4313204511C207001950 @default.
• W4313204511 hasConceptScore W4313204511C2775960820 @default.
• W4313204511 hasConceptScore W4313204511C2776561140 @default.
• W4313204511 hasConceptScore W4313204511C2776914184 @default.
• W4313204511 hasConceptScore W4313204511C2777587049 @default.
• W4313204511 hasConceptScore W4313204511C2777642821 @default.
• W4313204511 hasConceptScore W4313204511C2778698245 @default.
• W4313204511 hasConceptScore W4313204511C2779234561 @default.
• W4313204511 hasConceptScore W4313204511C2780269544 @default.
• W4313204511 hasConceptScore W4313204511C2780381497 @default.
• W4313204511 hasConceptScore W4313204511C2780394083 @default.
• W4313204511 hasConceptScore W4313204511C2780559512 @default.
• W4313204511 hasConceptScore W4313204511C46973012 @default.
• W4313204511 hasConceptScore W4313204511C54355233 @default.
• W4313204511 hasConceptScore W4313204511C55493867 @default.
• W4313204511 hasConceptScore W4313204511C71924100 @default.
• W4313204511 hasConceptScore W4313204511C74373430 @default.
• W4313204511 hasConceptScore W4313204511C86803240 @default.
• W4313204511 hasConceptScore W4313204511C98274493 @default.
• W4313204511 hasIssue "2" @default.
• W4313204511 hasLocation W43132045111 @default.
• W4313204511 hasLocation W43132045112 @default.
• W4313204511 hasOpenAccess W4313204511 @default.
• W4313204511 hasPrimaryLocation W43132045111 @default.
• W4313204511 hasRelatedWork W1967382410 @default.
• W4313204511 hasRelatedWork W2063539948 @default.
• W4313204511 hasRelatedWork W2134323468 @default.
• W4313204511 hasRelatedWork W2172298059 @default.
• W4313204511 hasRelatedWork W2351254887 @default.
• W4313204511 hasRelatedWork W2389560401 @default.
• W4313204511 hasRelatedWork W2395458693 @default.
• W4313204511 hasRelatedWork W3028789482 @default.
• W4313204511 hasRelatedWork W3183188803 @default.
• W4313204511 hasRelatedWork W4238851624 @default.
• W4313204511 hasVolume "31" @default.
• W4313204511 isParatext "false" @default.
• W4313204511 isRetracted "false" @default.
• W4313204511 workType "article" @default.